Jens Benn Sørensen
Clinical Associate Professor
- 2017
- Published
Concomitant Driver Mutations in Advanced Stage Non-Small-Cell Lung Cancer of Adenocarcinoma Subtype with Activating EGFR-Mutation
Sørensen, Jens Benn, Grauslund, M., Melchior, L., Jakobsen, J. N. & Santoni Rugiu, Eric, 2017, In: Journal of Thoracic Oncology. 12, S1, p. S518-S519Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
- Published
Heterogeneous Resistance Mechanisms in Rebiopsies from EGFR-Mutated NSCLC: Transformation to SCLC; FGFR3 and T790M Mutations
Urbanska, E., Grauslund, M., Melchior, L., Sørensen, Jens Benn & Santoni Rugiu, Eric, 2017, In: Journal of Thoracic Oncology. 12, 11 - S2, p. S2203Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
- Published
Heterogeneous resistance mechanisms in an EGFR exon 19-mutated non-small cell lung cancer patient treated with erlotinib: Persistent FGFR3-mutation, localized transformation to EGFR-mutated SCLC, and acquired T790M EGFR-mutation
Santoni Rugiu, Eric, Grauslund, M., Melchior, L. C., Costa, J. C., Sørensen, Jens Benn & Urbanska, E. M., 2017, In: Lung Cancer. 113, p. 14-17 4 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Implementation of lung cancer CT screening in the Nordic countries
Pedersen, J. H., Sørensen, Jens Benn, Saghir, Z., Fløtten, Ø., Brustugun, O. T., Ashraf, H., Strand, T., Friesland, S., Koyi, H., Ek, L., Nyrén, S., Bergman, P., Jekunen, A., Nieminen, E. & Gudbjartsson, T., 2017, In: Acta Oncologica. 56, 10, p. 1249-1257Research output: Contribution to journal › Review › Research › peer-review
- Published
Nintedanib Plus Pemetrexed/Cisplatin in Patients With Malignant Pleural Mesothelioma: Phase II Results From the Randomized, Placebo-Controlled LUME-Meso Trial
Grosso, F., Steele, N., Novello, S., Nowak, A. K., Popat, S., Greillier, L., John, T., Leighl, N. B., Reck, M., Taylor, P., Planchard, D., Sørensen, Jens Benn, Socinski, M. A., von Wangenheim, U., Loembé, A. B., Barrueco, J., Morsli, N. & Scagliotti, G., 2017, In: Journal of Clinical Oncology. 35, 31, p. 3591-3600Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The prevalence of ALK rearrangement in pulmonary adenocarcinomas in an unselected Caucasian population from a defined catchment area: impact of smoking
Skov, B. G., Clementsen, P., Larsen, Klaus Richter, Sørensen, Jens Benn & Mellemgaard, A., 2017, In: Histopathology. 70, 6, p. 889-895Research output: Contribution to journal › Journal article › Research › peer-review
ID: 34406177
Most downloads
-
162
downloads
Molecular prediction of adjuvant cisplatin efficacy in Non-Small Cell Lung Cancer (NSCLC)—validation in two independent cohorts
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
99
downloads
Concomitant driver mutations in advanced EGFR-mutated non-small-cell lung cancer and their impact on erlotinib treatment
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
72
downloads
Very Early Response Evaluation by PET/MR in Patients with Lung Cancer: Timing and Feasibility
Research output: Contribution to journal › Journal article › Research › peer-review
Published